Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7759/cureus.14928 http://scihub22266oqcxt.onion/10.7759/cureus.14928 34123627!8189533!34123627     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cureus 2021 ; 13 (5): e14928 Nephropedia Template TP {{tp|p=34123627|t=2021. Favipiravir-Induced Drug Fever in a Young Adult COVID-19 Patient |pdf=|usr=}}{{34123627}} gab.com Text Favipiravir-Induced Drug Fever in a Young Adult COVID-19 Patient JO: Cureus http://www.kidney.de/pget.php?&tw=1&pmid=34123627 #FOAvip Severe acute respiratory syndrome coronavirus 2 has had an indelible effect, with 153,738,171 cases recorded globally as per the World Health Organization's dashboard. The medical establishment is racing to find repurposed medications that can be successful against this novel coronavirus due to a shortage of new drugs to treat the disease. Favipiravir, an antiviral drug originally developed for influenza, is one of the drugs that has recently received a lot of attention, particularly in India. Here, we present a case of favipiravir-induced drug fever in a young adult coronavirus disease 2019 patient. Twit Text FOAVip Favipiravir-Induced Drug Fever in a Young Adult COVID-19 Patient ????Cureus http://www.kidney.de/pget.php?&tw=1&pmid=34123627 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34123627 #FOAvip English Wikipedia <ref>{{Cite pmid|34123627}}</ref> Favipiravir-Induced Drug Fever in a Young Adult COVID-19 Patient #MMPMID34123627 Jadeja DM; Patel NR Cureus 2021[May]; 13 (5): e14928 PMID34123627show ga Severe acute respiratory syndrome coronavirus 2 has had an indelible effect, with 153,738,171 cases recorded globally as per the World Health Organization's dashboard. The medical establishment is racing to find repurposed medications that can be successful against this novel coronavirus due to a shortage of new drugs to treat the disease. Favipiravir, an antiviral drug originally developed for influenza, is one of the drugs that has recently received a lot of attention, particularly in India. Here, we present a case of favipiravir-induced drug fever in a young adult coronavirus disease 2019 patient. äFavipiravir-Induced Drug Fever in a Young Adult COVID-19 Patient (epmc).pdf DeepDyve Pubget Overpricing